# TG Therapeutics

**Source:** https://www.startuphub.ai/startups/tg-therapeutics
**Profile type:** Startup

> A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases.

## About

TG Therapeutics is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for patients with B-cell malignancies and autoimmune diseases. The company's pipeline includes a combination of novel small molecules and antibodies designed to target key pathways involved in these diseases. Their lead programs, ublituximab and umbralisib, are being investigated in various hematologic cancers and autoimmune conditions.

## Key facts

- **Slug:** tg-therapeutics
- **Website:** https://www.tgtherapeutics.com/
- **Location:** New York, New York, USA
- **Founded:** 2011-01-01 00:00:00
- **Employees:** 497
- **Operating status:** Active
- **Total funding:** $360M
- **Sectors / tags:** Biotechnology, Pharmaceuticals, Healthcare
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/tg-therapeutics/
  - Twitter: https://twitter.com/TG_Therapeutics

## Frequently asked

### What does TG Therapeutics do?

TG Therapeutics is a commercial-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for patients with B-cell malignancies and autoimmune diseases. The company's pipeline includes a combination of novel small molecules and antibodies designed to target key pathways involved in these diseases. Their lead programs, ublituximab and umbralisib, are being investigated in various hematologic cancers and autoimmune conditions.

### What is TG Therapeutics's revenue?

StartupHub estimates TG Therapeutics's annual revenue at $68.9M (range $39.0M to $179.1M, 68% confidence), based on comparable companies in the sector.

### What is TG Therapeutics's valuation?

StartupHub estimates TG Therapeutics's effective valuation at $1.6B (range $1.6B to $19.6B, 43% confidence), based on comparable companies in the sector.

### How much funding has TG Therapeutics raised?

TG Therapeutics has raised a total of $360M in funding. The most recent round on record is Public Stock Offering.

### Where is TG Therapeutics headquartered?

TG Therapeutics is headquartered in New York, New York, USA.

### When was TG Therapeutics founded?

TG Therapeutics was founded in 2011.

### What industry does TG Therapeutics operate in?

TG Therapeutics operates in Biotechnology, Pharmaceuticals, Healthcare.

### How many employees does TG Therapeutics have?

TG Therapeutics has approximately 497 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "TG Therapeutics",
          "item": "https://www.startuphub.ai/startups/tg-therapeutics"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/tg-therapeutics#webpage",
      "url": "https://www.startuphub.ai/startups/tg-therapeutics",
      "name": "TG Therapeutics - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of TG Therapeutics. TG Therapeutics is a startup founded in 2011, operating in Biotechnology and Pharmaceuticals. A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases. Headquartered in New York, New York, USA. The company has approximately 497 employees.",
      "dateModified": "2026-05-01T10:39:55.16296+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/tg-therapeutics#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/tg-therapeutics#organization",
      "name": "TG Therapeutics",
      "url": "https://www.tgtherapeutics.com/",
      "description": "This is the official profile of TG Therapeutics. TG Therapeutics is a startup founded in 2011, operating in Biotechnology and Pharmaceuticals. A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases. Headquartered in New York, New York, USA. The company has approximately 497 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/tg-therapeutics/",
        "https://twitter.com/TG_Therapeutics",
        "https://www.startuphub.ai/startups/tg-therapeutics"
      ],
      "foundingDate": "2011-01-01 00:00:00",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 497
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "New York",
        "addressRegion": "New York",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Pharmaceuticals",
        "Healthcare"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/tg-therapeutics#profile-assessment",
      "name": "TG Therapeutics - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/tg-therapeutics",
      "category": "Biotechnology",
      "description": "This is the official profile of TG Therapeutics. TG Therapeutics is a startup founded in 2011, operating in Biotechnology and Pharmaceuticals. A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases. Headquartered in New York, New York, USA. The company has approximately 497 employees. Agent Readiness score: 41/100. Full audit: https://www.startuphub.ai/startups/tg-therapeutics/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "TG Therapeutics"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-05-01",
        "name": "TG Therapeutics - Profile Score 49/100",
        "reviewBody": "This is the official profile of TG Therapeutics. TG Therapeutics is a startup founded in 2011, operating in Biotechnology and Pharmaceuticals. A commercial-stage immunotherapy company focused on the development of novel treatments for B-cell malignancies and autoimmune diseases. Headquartered in New York, New York, USA. The company has approximately 497 employees. Agent Readiness score: 41/100. Full audit: https://www.startuphub.ai/startups/tg-therapeutics/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 49,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```